Register
Forgot your password?

Multidisciplinary approach in a Heart Team concept –direct strategy in optimization of treatment for coronary lesions

Authors: K.V. Petrosian

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

Type:  Reviews


DOI: https://doi.org/10.24022/0236-2791-2018-60-4-287-293

For citation: Petrosian K.V. Multidisciplinary approach in a Heart Team concept – direct strategy in optimization of treatment for coronary lesions. Russian Journal of Thoracic and Cardiovascular Surgery. 2018; 60 (4): 287–93 (in Russ.). DOI: 10.24022/0236-2791-2018-60-4-287-293

Received / Accepted:  18.01.2018/23.01.2018

Keywords: ischemic heart disease multidisciplinary approach Heart Team

Download
Full text:  

 

Abstract

Difficulties in choosing the method of revascularization based on data on the coronary lesions anatomy, especially in case of combined comorbidities, the probability of complications in the postoperative period often cause initially high surgical risk and determine the need for a multidisciplinary approach in the treatment of such patients. The concept of Heart Team induces more and more interest now. It involves the collaborative work of doctors of various specialties whose theoretical knowledge and personal practical experience allow to develop an individual treatment plan for each patient taking into account all the parameters.

The main task of the Heart Team is the optimization of decision-making for complex patients which is getting more complicated with the development of technology and the accumulation of data from large randomized trials. This principle provides an excellent opportunity for the detailed discussion of a patient, falling into the intermediate zone of the comhaving a strong comorbidity. It is a highly productive and effective form of interdisciplinary cooperation of the qualified healthcare professionals in a cardiovascular surgical centre that helps to determine the best-weighted treatment options oriented on a patient's benefits and interests.

The article presents the history of the concept's development. Its feasibility in the treatment of patients with coronary heart disease, the principles of the Heart Team organization are discussed. The difficulties associated with the introduction of the multidisciplinary approach are specially considered.plexity of the coronary lesion and/or

References

  1. Mendis S., Puska P., Norrving B. (Eds.) Global atlas on cardiovascular disease prevention and control. World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, Geneva; 2011: 6.
  2. Бокерия Л.А., Гудкова Р.Г. Сердечно-сосудистая хирургия – 2015. Болезни и врожденные аномалии системы кровообращения. М.: НЦССХ им. А.Н. Бакулева РАМН; 2016: 5–8. [Bockeria L.A., Gudkova R.G. Cardiovascular surgery – 2015. Diseases and congenital anomalies of the circulatory system. Moscow; 2016: 5–8 (in Russ.).]
  3. Бокерия Л.А., Глянцев С.П. «Cлoвa не имеют смысла, если они poдились не после длительного пути под звездами…» Эпигpaфика на книгах из личной библиотеки В.И. Бypaкoвскoгo (к 95-летию со дня рождения). Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2017; 18 (6): 665–88. DOI: 10.24022/1810-0694- 2017-18-6-665-688 [Boсkeria L.A., Glyantsev S.P. “The words do not have a meaning, if they were not after a long road under stars...” Epigraphic on books from V.I. Burakovsky personal library (on the 95th anniver sary of his birth). Cardiovascular Diseases. Bulletin of Bakoulev Center for Cardiovascular Surgery. 2017; 18 (6): 665–88 (in Russ.). DOI: 10.24022/1810-0694-2017-18-6-665-688]
  4. Rousseau H., Puel J., Joffre F., Sigwart U., Duboucher C., Imbert C. et al. Self-expanding endovascular prosthesis: an experimental study. Radiology. 1987; 164 (3): 709–14. DOI: 10.1148/radiology.164.3.3303120
  5. Sigwart U., Puel J., Mirkovitch V., Joffre F., Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N. Engl. J. Med. 1987; 316 (12): 701–6. DOI: 10.1056/NEJM198703193161201
  6. Head S.J., Kaul S., Mack M.J., Serruys P.W., Taggart D.P., Holmes D.R. Jr. et al. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease. Eur. Heart J. 2013; 34 (32): 2510–8. DOI: 10.1093/eurheartj/eht059
  7. Mohr F.W., Morice M.C., Kappetein A.P., Feldman T.E., Sta° hle E., Colombo A. et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with threevessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet. 2013; 381 (9867): 629–38. DOI: 10.1016/S0140-6736(13)60141-5
  8. Balmer F., Rotter M., Togni M., Pfiffner D., Zeiher A.M., Maier W., Meier B. Percutaneous coronary interventions in Europe 2000. Int. J. Cardiol. 2005; 101 (3): 457–63. DOI: 10.1016/j.ijcard. 2004.03.064
  9. Epstein A.J., Polsky D., Yang F., Yang L., Groeneveld P.W. Coronary revascularization trends in the United States, 2001–2008. JAMA. 2011; 305 (17): 1769–76. DOI: 10.1001/jama.2011.551
  10. Hassan A., Newman A., Ko D.T., Rinfret S., Hirsch G., Ghali W.A., Tu J.V. Increasing rates of angioplasty versus bypass surgery in Canada, 1994–2005. Am. Heart J. 2010; 160 (5): 958–65. DOI: 10.1016/j.ahj.2010.06.052
  11. Stefanini G.G., Holmes D.R. Jr. Drug-eluting coronary-artery stents. N. Engl. J. Med. 2013; 368 (3): 254–65. DOI: 10.1056/ NEJMra1210816
  12. Алекян Б.Г., Григорьян А.М., Стаферов А.В. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации. М.: ЛА Графикс; 2016: 62. [Alekyan B.G., Grigor'yan A.M., Staferov A.V. Endovascular diagnostics and treatment of cardiovascular diseases in the Russian Federation (2015). Moscow: LA Grafiks; 2016: 62 (in Russ.).]
  13. OECD iLibrary. Health at a Glance 2015. Available at: https://www.oecd-ilibrary.org/social-issues-migration-health/ health-at-a-glance-2015_health_glance-2015-en (accessed August 6, 2018).
  14. Head S.J., Bogers A.J., Serruys P.W., Takkenberg J.J., Kappetein A.P. A crucial factor in shared decision making: the team approach. Lancet. 2011; 377 (9780): 1836. DOI: 10.1016/ S0140-6736(11)60775-7
  15. Chandrasekharan D.P., Taggart D.P. Informed consent for interventions in stable coronary artery disease: problems, etiologies, and solutions. Eur. J. Cardiothorac. Surg. 2011; 39 (6): 912–7. DOI: 10.1016/j.ejcts.2010.08.033
  16. Hannan E.L., Racz M.J., Gold J., Cozzens K., Stamato N.J., Powell T. et al. Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice? Circulation. 2010; 121 (2): 267–75. DOI: 10.1161/CIRCULATIONAHA.109.887539
  17. Kesson E.M., Allardice G.M., George W.D., Burns H.J., Morrison D.S. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ. 2012; 344: e2718. DOI: 10.1136/bmj.e2718
  18. King S.B. 3rd, Barnhart H.X., Kosinski A.S., Weintraub W.S., Lembo N.J., Petersen J.Y. et al. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am. J. Cardiol. 1997; 79 (11): 1453–9. DOI: 10.1016/s0002-9149(97)00170-7
  19. Feit F., Brooks M.M., Sopko G., Keller N.M., Rosen A., Krone R. et al. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation. 2000; 101 (24): 2795–802. DOI: 10.1161/01.cir.101.24.2795
  20. Shahian D.M., O'Brien S.M., Sheng S., Grover F.L., Mayer J.E., Jacobs J.P. et al. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT Study). Circulation. 2012; 125 (12): 1491–500. DOI: 10.1161/CIRCULATIONAHA.111.066902
  21. WeintraubW.S., Grau-Sepulveda M.V., Weiss J.M., O'Brien S.M., Peterson E.D., Kolm P. et al. Comparative effectiveness of revascularization strategies. N. Engl. J. Med. 2012; 366 (16): 1467–76. DOI: 10.1056/NEJMoa1110717
  22. Wu C., Camacho F.T., Zhao S., Wechsler A.S., Culliford A.T., Lahey S.J. et al. Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. Ann. Thorac. Surg. 2013; 95 (4): 1297–305. DOI: 10.1016/j.athoracsur. 2012.11.073
  23. Bruckel J.T., Gurm H.S., Seth M., Prager R.L., Jensen A., Nallamothu B.K. Use of a Heart Team in decision-making for patients with complex coronary disease at hospitals in Michigan prior to guideline endorsement. PLoS One. 2014; 9 (11): e113241. DOI: 10.1371/journal.pone.0113241
  24. Head S.J., Holmes D.R. Jr., Mack M.J., Serruys P.W., Mohr F.W., Morice M.C. et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries. JACC Cardiovasc. Interv. 2012; 5 (6): 618–25. DOI: 10.1016/j.jcin.2012.02.013
  25. Taggart D.P. CABG or stents in coronary artery disease: end of the debate? Lancet. 2013; 381 (9867): 605–7. DOI: 10.1016/ S0140-6736(13)60258-5
  26. Windecker S., Kolh P., Alfonso F., Collet J.P., Cremer J., Falk V. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2014; 35 (37): 2541–619. DOI: 10.1093/eurheartj/ ehu278
  27. Hillis L.D., Smith P.K., Anderson J.L., Bittl J.A., Bridges C.R., Byrne J.G. et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Thorac. Cardiovasc. Surg. 2012; 143 (1): 4–34. DOI: 10.1016/ j.jtcvs.2011.10.015
  28. Kirtane A.J., Doshi D., Leon M.B., Lasala J.M., Ohman E.M., O'Neill W.W. et al. Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention. Circulation. 2016; 134 (5): 422–31. DOI: 10.1161/CIRCULATIONAHA. 116.022061
  29. Hannan E.L., Cozzens K., Samadashvili Z., Walford G., Jacobs A.K., Holmes D.R. Jr. et al. Appropriateness of coronary revascularization for patients without acute coronary syndromes. J. Am. Coll. Cardiol. 2012; 59 (21): 1870–6. DOI: 10.1016/j.jacc.2012.01.050
  30. Chan P.S., Rao S.V., Bhatt D.L., Rumsfeld J.S., Gurm H.S., Nallamothu B.K. et al. Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions. J. Am. Coll. Cardiol. 2013; 62 (24): 2274–81. DOI: 10.1016/ j.jacc.2013.07.086
  31. Holmes D.R. Jr., Rich J.B., Zoghbi W.A., Mack M.J. The heart team of cardiovascular care. J. Am. Coll. Cardiol. 2013; 61 (9): 903–7. DOI: 10.1016/j.jacc.2012.08.1034
  32. Agarwal S., Tuzcu E.M., Kapadia S.R. Choice and selection of treatment modalities for cardiac patients: an interventional cardiology perspective. J. Am. Heart Assoc. 2015; 4 (10): e002353. DOI: 10.1161/JAHA.115.002353

About Authors

Karen V. Petrosian, Cand. Med. Sc., Head of Department, orcid.org/0000-0002-3370-0295

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by